D
Dorothy A. Shead
Researcher at National Comprehensive Cancer Network
Publications - 38
Citations - 8612
Dorothy A. Shead is an academic researcher from National Comprehensive Cancer Network. The author has contributed to research in topics: Prostate cancer & Breast cancer. The author has an hindex of 33, co-authored 35 publications receiving 7346 citations. Previous affiliations of Dorothy A. Shead include Ohio State University & Northwestern University.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines in oncology
William J. Gradishar,Benjamin O. Anderson,Ron Balassanian,Sarah L. Blair,Harold J. Burstein,Amy E. Cyr,Anthony D. Elias,William B. Farrar,Andres Forero,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Steven J. Isakoff,Janice A. Lyons,P. Kelly Marcom,Ingrid A. Mayer,Beryl McCormick,Meena S. Moran,Ruth O'Regan,Sameer A. Patel,Lori J. Pierce,Elizabeth C. Reed,Kilian E. Salerno,Lee S. Schwartzberg,Amy Sitapati,Karen L. Smith,Mary Lou Smith,Hatem Soliman,George Somlo,Melinda L. Telli,John H. Ward,Rashmi Kumar,Dorothy A. Shead +32 more
TL;DR: This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Journal ArticleDOI
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler,Emmanuel S. Antonarakis,Andrew J. Armstrong,Anthony V. D'Amico,Brian J. Davis,Tanya B. Dorff,James A. Eastham,Charles Arthur Enke,Thomas A. Farrington,Celestia S. Higano,Eric M. Horwitz,Michael E. Hurwitz,Joseph E. Ippolito,Christopher J. Kane,Michael Kuettel,Joshua M. Lang,Jesse K. McKenney,George J. Netto,David F. Penson,Elizabeth R. Plimack,Julio M. Pow-Sang,Thomas J. Pugh,Sylvia Richey,Mack Roach,Stan Rosenfeld,Edward M. Schaeffer,Ahmad Shabsigh,Eric J. Small,Daniel E. Spratt,Sandy Srinivas,Jonathan D. Tward,Dorothy A. Shead,Deborah A. Freedman-Cass +32 more
TL;DR: The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer.
Journal ArticleDOI
Prostate Cancer, Version 1.2016
James L. Mohler,Andrew J. Armstrong,Robert R. Bahnson,Anthony V. D'Amico,Brian J. Davis,James A. Eastham,Charles Arthur Enke,Thomas A. Farrington,Celestia S. Higano,Eric M. Horwitz,Michael E. Hurwitz,Christopher J. Kane,Mark H. Kawachi,Michael Kuettel,Richard T. Lee,Joshua J. Meeks,David F. Penson,Elizabeth R. Plimack,Julio M. Pow-Sang,David Raben,Sylvia Richey,Mack Roach,Stan Rosenfeld,Edward M. Schaeffer,Ted A. Skolarus,Eric J. Small,Guru Sonpavde,Sandy Srinivas,Seth A. Strope,Jonathan D. Tward,Dorothy A. Shead,Deborah A. Freedman-Cass +31 more
TL;DR: This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.
Journal ArticleDOI
Prevention and treatment of cancer-related infections
Lindsey R. Baden,William Bensinger,Michael Angarone,Corey Casper,Erik R. Dubberke,Alison G. Freifeld,Ramiro Garzon,John N. Greene,John P. Greer,James I. Ito,Judith E. Karp,Daniel R. Kaul,Earl King,Emily R. Mackler,Kieren A. Marr,Jose G. Montoya,Ashley Morris-Engemann,Peter G. Pappas,Kenneth V. I. Rolston,Brahm H. Segal,Susan K. Seo,Sankar Swaminathan,Maoko Naganuma,Dorothy A. Shead +23 more
TL;DR: The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer.
Journal ArticleDOI
Invasive breast cancer version 1.2016
William J. Gradishar,Benjamin O. Anderson,Ronald Balassanian,Sarah L. Blair,Harold J. Burstein,Amy E. Cyr,Anthony D. Elias,William B. Farrar,Andres Forero,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Clifford A. Hudis,Steven J. Isakoff,P. Kelly Marcom,IA Mayer,Beryl McCormick,Meena S. Moran,Sameer A. Patel,Lori J. Pierce,Elizabeth C. Reed,Kilian E. Salerno,Lee S. Schwartzberg,Karen L. Smith,Mary Lou Smith,Hatem Soliman,George Somlo,Melinda L. Telli,John H. Ward,Dorothy A. Shead,Rashmi Kumar +30 more
TL;DR: The NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body) are outlined, and the management of clinical stage I, II, and IIIA (T3N1M0) tumors are discussed.